Most MedTech companies don't slow down because they run out of opportunity.
They slow down because complexity begins growing faster than leadership, communication and execution can keep pace.
In this opening episode of Signal Before Scale™ Conversations, Harun Rabbani explores the hidden forces that quietly undermine momentum inside growing MedTech organisations. From leadership bottlenecks and decision-making friction to organisational misalignment and execution drift, this episode examines the early warning signs that often appear long before performance begins to decline.
Designed for founders, CEOs, executive teams, investors and ecosystem leaders, this conversation challenges the assumption that scale is simply a question of funding, talent or innovation.
The real challenge may be something far less visible. And far more important.